AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in AIM ImmunoTech Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −1 vs. Q2 2021
- Shares held
- 7.30M
- +94.9K (+1.3%) vs. Q2 2021
- Total value
- $14.7M
- −$746.0K (−4.8%) vs. Q2 2021
- New holders
- 6
- 12 more added
- Sold out
- 7
- 7 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $325.6K |
| Q1 2026 | 18 | $102.8K |
| Q4 2025 | 13 | $119.8K |
| Q3 2025 | 15 | $293.9K |
| Q2 2025 | 12 | $104.8K |
| Q1 2025 | 34 | $590.0K |
| Q4 2024 | 35 | $919.3K |
| Q3 2024 | 33 | $2.43M |
| Q2 2024 | 36 | $3.15M |
| Q1 2024 | 33 | $1.93M |
| Q4 2023 | 38 | $1.83M |
| Q3 2023 | 38 | $1.97M |
| Q2 2023 | 34 | $3.01M |
| Q1 2023 | 36 | $2.05M |
| Q4 2022 | 39 | $1.67M |
| Q3 2022 | 38 | $3.36M |
| Q2 2022 | 40 | $4.68M |
| Q1 2022 | 38 | $7.12M |
| Q4 2021 | 43 | $6.86M |
| Q3 2021 | 38 | $14.7M |
| Q2 2021 | 39 | $15.5M |
| Q1 2021 | 38 | $16.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding AIM ImmunoTech Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 2,384,379 | $4.82M | 0.00% | −123,011−4.9% | Reduced |
| Vanguard Group Inc | 2,002,856 | $4.05M | 0.00% | +9,700+0.5% | Added |
| BlackRock Inc. | 828,158 | $1.67M | 0.00% | +5,468+0.7% | Added |
| Geode Capital Management, LLC | 372,953 | $753.0K | 0.00% | +21,203+6.0% | Added |
| Dimensional Fund Advisors LP | 370,643 | $749.0K | 0.00% | +231,483+166.3% | Added |
| Bridgeway Capital Management, LLC | 236,000 | $477.0K | 0.01% | −10,000−4.1% | Reduced |
| State Street Corp | 160,413 | $324.0K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 148,479 | $300.0K | 0.00% | +40,479+37.5% | Added |
| Price T Rowe Associates Inc | 116,800 | $236.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 88,416 | $179.0K | 0.00% | +1,190+1.4% | Added |
| Winton Group Ltd | 82,564 | $167.0K | 0.01% | +27,670+50.4% | Added |
| Millennium Management LLC | 54,376 | $110.0K | 0.00% | +54,376 | New |
| Raymond James Financial Services Advisors, Inc. | 48,450 | $98.0K | 0.00% | +500+1.0% | Added |
| Cambridge Investment Research Advisors, Inc. | 46,679 | $94.0K | 0.00% | 00.0% | Unchanged |
| SeaCrest Wealth Management, LLC | 43,563 | $88.0K | 0.01% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 41,095 | $82.0K | 0.00% | −26,076−38.8% | Reduced |
| Rockefeller Capital Management L.P. | 40,000 | $80.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 36,149 | $73.0K | 0.00% | +36,149 | New |
| Bank of New York Mellon Corp | 27,565 | $56.0K | 0.00% | +2,297+9.1% | Added |
| Arkadios Wealth Advisors | 21,597 | $43.0K | 0.01% | +21,597 | New |
| Captrust Financial Advisors | 20,000 | $40.0K | 0.00% | 00.0% | Unchanged |
| Alpine Global Management, LLC | 18,774 | $38.0K | 0.01% | +18,774 | New |
| LPL Financial LLC | 16,482 | $33.0K | 0.00% | −543−3.2% | Reduced |
| Qube Research & Technologies Ltd | 15,826 | $32.0K | 0.00% | +15,826 | New |
| Bank of America Corp | 15,706 | $31.0K | 0.00% | +683+4.5% | Added |
| Community Bank, N.A. | 13,226 | $27.0K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 11,200 | $23.0K | 0.00% | −11,900−51.5% | Reduced |
| Traynor Capital Management, Inc. | 11,777 | $23.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 10,793 | $22.0K | 0.00% | −16−0.1% | Reduced |
| SNS Financial Group, LLC | 10,000 | $20.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,598 | $5.00K | 0.00% | +199+8.3% | Added |
| Advisor Group Holdings, Inc. | 1,455 | $3.00K | 0.00% | +600+70.2% | Added |
| Howe & Rusling Inc | 1,500 | $3.00K | 0.00% | +1,500 | New |
| Proequities, Inc. | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 228 | $461 | 0.00% | 00.0% | Unchanged |
| Huntington National Bank | 57 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 10 | $0 | 0.00% | −7−41.2% | Reduced |
| Jacobi Capital Management LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −152,848−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −29,269−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −20,316−100.0% | Sold out |
| Lehman & Derafelo Financial Resources LLC | 0 | $0 | 0.00% | −11,100−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −9,733−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −14−100.0% | Sold out |